Company intelligence / Profile preview

Fidmi Medical

Caesarea, Haifa District, Israelfidmimedical.com ↗

Ownership: Private
Development stage: Commercial

Overview

Fidmi Medical has developed a novel low-profile percutaneous endoscopic gastrostomy (PEG) device designed for easy insertion, replacement, and removal. The device aims to reduce complications associated with traditional gastric tubes and improve patient quality of life. It received FDA 510(k) clearance in 2019 and began U.S. commercialization in 2021.

Therapeutic areas: Gastroenterology
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

US distributor partnership with MT Endoscopy

Beyond the preview

Go deeper on Fidmi Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fidmi Medical.

Explore the full profile